Powered by


                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Health Questions

   News via RSS






   Forum Archives





















   Primary Care






   Other Sections


   Research Tools

   Medical Tutorials

   Medical Software




Back to Oncology Diseases

Chronic myeloid leukemia

Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disorder resulting from the neoplastic transformation of the primitive hemopoietic stem cell. The disease is monoclonal in origin, affecting myeloid, monocytic, erythroid, megakaryocytic, B-cell, and, sometimes, T-cell lineages.


CML accounts for 15% of all leukemias in adults. In adults the incidence is approximately 1 to 1.5 cases per 100,000 population.

Estimated new cases and deaths from chronic myeloid leukemia in the United States in 2005:

  • New cases: 4,600
  • Deaths: 850


The male-to-female ratio is 1.4 to 2.2:1.


The median age of patients with Ph1-positive CML (Chronic Myeloid Leukemia) is 67 years of age.

Race and ethnicity

Incidence rates are similar among all race/ethnicities.

advertisement.gif (61x7 -- 0 bytes)

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application


CML has been observed in studies following the atom bomb explosions in Japan in 1945.

previous.gif (72x17 -- 347 bytes) next.gif (72x17 -- 277 bytes)



 advertisement.gif (61x7 -- 0 bytes)



Copyright 2001-2017
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Links | Humor
Forum Archive
CME Articles

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email